The major factors driving the growth of this market include the increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure.
The Slide Stainer market was valued at USD 2.52 billion in 2017 and is expected to reach USD 4.70 billion in 2023, at a CAGR of 11.0% during the forecast period.
+ Market Dynamics
+ Increasing Incidence of Chronic Diseases
+ Rising Geriatric Population
+ Increasing Automation in Laboratories
+ Increasing Healthcare Expenditure
Download PDF Brochure @
By product, the reagents segment accounted for the largest share of the slide stainers market in 2017
The reagents segment accounted for the largest share of the global slide stainers market in 2017. The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.
By technology, the hematoxylin & eosin (H&E) segment held the largest share in 2017
The slide stainers market is segmented into hematoxylin and eosin (H&E), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains. In 2017, the H&E segment accounted for the largest share of the slide stainers market. The large share of this segment can be attributed to the fact that H&E staining is the initial staining technique for various diseases and is associated with better quality, ease of use, and higher throughput than most other staining technologies.
View complete press release:-